becton dickinson co januari
becton dickinson co
histor year success complet acquisit bard
recommend buy rate tp
deriv tp base non-gaap ep
forward price-to-earnings multipl provid upsid
potenti expect top-lin
revenu growth
estim base follow factor strong
revenu growth across three segment acquisit
bard tva medic robust margin expans strong
growth new product uptak
report strong growth revenu due growth
across three segment success complet
acquisit bard total revenu beat estim
increas y/i
gaap ep declin y/i due purchas
account expens relat acquisit
addit tax expens relat new tax legisl
non-gaap ep also beat estim
increas y/i
mn except ep
medic segment revenu increas
increas y/i revenu
medic deliveri solut grew
grew due strength vascular access
infus dispos
compani namebecton dickinson tickerbdxstock ratingbuyunchangedindustri viewoverweightpositivepric dec week week volum volum ep margin margin ttm per share growth profit ttm ttm incom ttm earn growth yoy n/acrispideaakansha becton dickinson co januari
incom statement
non-
per share item
balanc sheet
product perform develop
valuat consensu perform
becton dickinson co januari
bd life scienc segment revenu increas
increas
increas due strong perform
across segment
total revenu diagnost system grew
quarter perform driven instrument
microbiolog platform includ blood cultur tb
idast strong kiestra instal bd molecular
intervent segment revenu
due strong perform peripher intervent
urolog critic care unit
revenu grew
due strong growth
pharmaceut system unit within bd medic
revenu grew due
strong perform three busi segment
particularli asia pac latin america ema
current price-to-earnings averag price-to-earnings
due fall stock price quarter
price-to-earnings trail
avg-stdev past expect forward
price-to-earnings multipl
sinc stock price declin last didnt
reach tp recommend tp
well base perform
acquisit bard
stock price histori date high obsolet date obsolet move move share statist averag volum averag volum share held held share short short share short prior month error dividend split forward annual dividend forward annual dividend trail annual dividend trail annual dividend year averag dividend pay-out dividend date dec ex-dividend date dec last split factor new per last split date aug inform becton dickinson co januari
incom statement
non-
per share item
balanc sheet
product perform develop
valuat consensu perform
becton dickinson co januari
non- reconcili refer page
incom statement total gross research sale gener restructur merger oper total oper oper interest incom incom provis incom net prefer net incom avail common weight averag share estim annual actual annual actual quarterli becton dickinson co januari
prepaid current total current net properti plant equiti intang long-term total non-curr total short-term account tax accru current total current long-term defer tax long-term total non-curr total prefer common addit paid-in retain treasuri accumul comprehens total stockhold total liabil stockhold balanc sheet itemsactu annual actual quarterli becton dickinson co januari
net cash provid oper activ compar
attribut net incom adjust depreci amort non-cash item
net cash use invest activ compar
increas due capit expenditur acquisit divestitur busi
net cash use financ activ compar net cash provid financ
activ
depreci defer incom stock base chang work account prepaid work non-cash net cash provid oper invest properti plant acquisit purchas sales/matur invest net cash use invest debt debt common stock common stock excess tax benefit stock base dividend financ net cash provid use financ effect exchang rate net chang begin end becton dickinson co januari
becton dickinson co deliv strong perform quarter
growth revenu due acquisit bard strong
total revenu increas compar
due acquisit bard currency-neutr
basi revenu increas prior-year period
total revenu increas
compar total intern revenu increas
compar
cog increas compar
adjust gross margin increas compar
sg expens increas compar
adjust sg expens revenu
compar
compar
due acquisit
compar
 expens increas compar
adjust expens revenu
compar
acquisit restructur cost increas
compar oper incom increas
compar adjust
oper margin increas compar
interest expens increas compar
interest incom declin
compar incom
compar expens
becton dickinson co januari
gaap ep decreas
compar
increas
compar
incom tax provis compar incom tax
benefit adjust tax rate
compar
net loss compar net incom
adjust net incom increas
compar
gaap ep decreas compar
non-gaap ep increas compar
compar
total revenu increas compar
due acquisit bard increas reflect
impact almost result acquisit bard growth also
reflect volum growth favor impact foreign currenc
translat unfavor impact price
compar currency-neutr basi revenu grew
includ estim bp advers impact chang
 dispens busi model estim sale impact hurrican
maria puerto rico bard busi bd
cog increas compar
sg expens increas compar
sg expens revenu compar
increas due inclus bard
higher sg spend profil result
 expens increas compar
 expens revenu compar
becton dickinson co januari
acquisit restructur increas
compar due acquisit bard
interest expens increas compar
increas reflect higher level debt due
issuanc senior unsecur note
interest incom decreas compar
decreas interest incom reflect lower cash level subsequ
close bard acquisit
tax rate compar increas
effect incom tax rate reflect certain effect new tax
legisl enact decemb net incom declin
compar
gaap ep declin compar
declin due purchas account expens relat
acquisit addit tax expens relat new tax legisl
off-set non-cash charg prior year relat chang
dispens model adjust ep increas
compar
gaap ep declin
due
purchas account
expens relat
acquisit
relat new tax
legisl off-set
non-cash charg
prior year relat
chang
becton dickinson co januari
total revenu increas
compar compar basi revenu
increas prior-year period includ
estim bp advers impact chang dispens
busi model hurrican maria
total revenu
 increas
compar
total revenu increas
compar prior-year period compar basi revenu
increas prior-year period growth due
strong perform medic manag solut
pharmaceut system unit within bd medic segment
total revenu
increas
compar prior-
total intern revenu increas
compar compar currency-neutr basi
revenu outsid increas prior-
report revenu outsid increas
prior-year period due acquisit bard
compar currency-neutr basi revenu outsid increas
prior-year period
revenu benefit inclus revenu associ
bard product financi result revenu also reflect
increas sale medic segment medic deliveri solut
medic manag solut pharmaceut system unit well
growth attribut sale three life scienc segment
total revenu emerg market increas
compar prior-year period total revenu increas
compar prior-year period foreign currenc
translat favor impact emerg market revenu
estim emerg market revenu growth benefit
inclus revenu associ bard product financi result
underli growth particularli driven sale china ema
becton dickinson co januari
total revenu china increas
compar prior-year period total revenu china increas
compar prior-year period
total revenu develop market increas
compar prior-year period total revenu increas
compar prior-year period
total revenu
china increas
compar prior-
becton dickinson co januari
bdx organiz structur base upon three princip busi segment
bd medic bd life scienc bd intervent
total revenu medic segment increas
compar total revenu segment
increas compar
total revenu increas
compar total revenu increas
compar
total intern revenu increas
compar total intern revenu increas
compar
oper incom increas compar
oper margin increas compar
medic segment growth favor impact inclus
revenu associ certain bard product within medic
deliveri solut unit begin januari
medic segment underli revenu growth led sale
medic deliveri solut unit vascular access vascular care
product well medic manag solut unit
instal dispens infus system
total revenu medic deliveri solut increas
compar total revenu increas
compar
total revenu
increas
compar
total revenu
solut increas
compar
becton dickinson co januari
total revenu increas
compar total revenu increas
compar
total intern revenu increas
compar total intern revenu increas
compar
total revenu
increas
compar
total revenu
compar
total revenu medic manag solut increas
compar total
revenu increas compar
total revenu increas
compar total revenu increas
compar
total intern revenu increas
compar total intern revenu increas
compar
total revenu diabet care increas
compar total revenu increas
compar
total revenu increas
compar total revenu increas
compar
becton dickinson co januari
total intern revenu decreas
compar total intern revenu increas
compar
total revenu pharmaceut system increas
compar total revenu increas
compar
total revenu increas
compar total revenu increas
compar
total intern revenu increas
compar total intern revenu increas
compar
total revenu life scienc segment increas
compar total revenu increas
compar
total revenu increas
compar total revenu increas
compar
total intern revenu increas
compar total intern revenu increas
compar
total revenu
increas
compar
total revenu life
increas
compar
total revenu
increas
compar
total revenu
increas
compar
becton dickinson co januari
oper profit increas compar
oper margin increas
compar
life scienc segment revenu growth led growth across
three organiz unit diagnost system unit revenu
led sale core microbiolog product well continu
strength sale unit bd maxtm molecular platform revenu
growth diagnost system unit also reflect sever
influenza season compar
life scienc segment revenu growth also due
bioscienc unit sale research reagent recent launch
instrument growth preanalyt system unit reflect global
sale core product
total revenu preanalyt increas
compar total revenu increas
compar
total revenu increas
compar total revenu increas
compar
total intern revenu increas
compar total intern revenu increas
compar
total revenu diagnost system increas
compar total revenu increas
compar
becton dickinson co januari
total revenu
bioscienc increas
compar
total revenu increas
compar total revenu increas
compar
total intern revenu increas
compar total intern revenu increas
compar
total revenu
increas
compar
total revenu bioscienc increas
compar total revenu increas
compar
total revenu increas
compar total revenu increas
compar
total intern revenu increas
compar total intern revenu increas
compar
total revenu intervent segment increas
compar total revenu increas
compar
total revenu increas compar
total revenu increas
compar
becton dickinson co januari
total intern revenu increas compar
total intern revenu increas
compar
oper profit increas compar
oper margin increas
intervent segment oper incom due perform
respect gross profit margin oper expens oper
incom reflect expens relat recognit fair valu
step-up adjust relat bard inventori acquisit date
total revenu surgeri busi increas
compar total revenu increas
compar
total revenu increas compar
total revenu increas
compar
total intern revenu increas compar
total intern revenu increas
compar
total revenu peripher intervent increas
compar total revenu increas
compar
total revenu increas compar
total revenu increas
compar
total revenu
increas
compar
total revenu
increas
compar
becton dickinson co januari
total intern revenu increas compar
total intern revenu increas
compar
urolog critic
total revenu urolog critic busi
total revenu
total intern revenu
total revenu
urolog critic
busi
becton dickinson co januari
becton dickinson co januari
total revenu
expect grow
rang
ssg sale
 sale
adjust ep growth
expect
total revenu expect grow rang
adjust ep growth expect
effect tax rate expect
gross margin expect
oper expect
becton dickinson co januari
report strong result due acquisit bard total revenu
increas ep declin
due purchas account expens relat
acquisit addit tax expens relat new tax legisl
adjust ep increas
medic segment revenu increas increas
y/i revenu medic deliveri solut
grew grew due strength
vascular access infus dispos
bd life scienc segment revenu increas
increas increas due strong
perform across segment intervent segment revenu
due strong perform peripher intervent
urolog critic care
revenu grew due strong
growth pharmaceut system unit within bd medic
segment emerg market revenu grew
strong growth china increas revenu
achiev target cumul annual carefus cost
synergi realiz bard cost synergi new
product innov continu fuel growth new alari
pyxi es medic segment bd bd facslyr continu
expans bd horizon brilliant dye life scienc lutonix av
covera intervent segment
success complet complet acquisit
bard strong perform across segment enter
continu strong momentum confid abil execut
complet
complet
acquisit bard
across segment
becton dickinson co januari
non- reconcili
non- reconcili
non- reconcili
oper tax oper tax becton dickinson co januari
incom statement
non-
per share item
balanc sheet
product perform develop
valuat consensu perform
becton dickinson co januari
revenu growth compar
ep growth compar
oper margin compar due increas sg expens
gross margin declin compar due increas cog
ratio revenu margin margin inc margin rate margin turnov averag asset leverag averag equiti year averag averag averag year averag averag averag year averag averag averag growth growth ex sale /sale /net incom ratio profit marginsprofitabilityrevenu growth oper incom growthep growth becton dickinson co januari
mrqgross mrqoper mrqnet mrqcog mrqsg mrqr sale becton dickinson co januari
inv flow sale
mrqfinanci mrqreturn mrqreturn mrqyoy growth revenu growthoper incom growthep mrq ratio growth yoy oper growth yoy free growth mrqcapex salescap ex salesfre /sale becton dickinson co januari
per share item ratio
fiscal per ebitda per ebit per earn per share ep ep free flow per dividend per book valu per tangibl book per month end stock month end stock equiti return asset return invest capit return capit joel greenblatt debt gross margin oper margin net margin total equiti total lt debt total asset dividend pay-out day sale day account day convers inventori cog inventori tax rate net incom net incom discontinued- net net margin prefer dividends- annual itemsquarterli item becton dickinson co januari
balanc sheet item
outstand equival market debt common prefer stock- purchas properti plant sale properti plant equipment- purchas sale business- purchas investment- sale issuanc stock- repurchas net issuanc prefer stock- net issuanc net chang capit free becton dickinson co januari
current price-to-earnings averag price-to-earnings due fall stock price
quarter price-to-earnings trail avg-stdev past
year expect forward price-to-earnings multipl
bandp/eaverageavg stdevavg stdev becton dickinson co januari
incom statement
non-
per share item
balanc sheet
product perform develop
valuat consensu perform
becton dickinson co januari
breakdown share held share held float held institut hold institut holdersholdershar report outvaluepric row associ fmr vanguard group inc jp morgan fundsmith well fargo putnam invest top mutual fund holdersholdersharesd report outvaluevanguard total stock market price row growth stock fund vanguard price row chip growth fund price row capit appreci spdr etf franklin manag trust rise dividend fidel select portfolio medic technolog devic vanguard institut fund-institut price row becton dickinson co januari
compani name/symbolcurr yr epsgrowthbecton dickinson lab minor becton dickinson co januari
developmentsbd complet molecular portfolio gi infect new viral paneldecemb announc food drug administr clearanc bd enter viral panel molecular diagnost test direct qualit detect differenti enter viral pathogen caus viral gastroenter compani offer broad suit solut detect intestin condit bacteri viral parasit origin clinic relev target panel bd expand integr medic manag help tackl hospit drug diversionnovemb announc launch new softwar applic design help hospit health system identifi drug divers societi health-system pharmacist ashp midyear meet bd announc clinic trial data lutonix drug-coat balloon below-the-kne trialnovemb announc safeti efficaci data lutonixdrug-co balloon dcb level clinic trial below-the-kne btk indic bd launch molecular test detect tuberculosi multi-drug resist tboctob announc avail bd mdr-tb panel europ clinician use test simultan detect bacteria caus tuberculosi tb determin bacteria contain mutat associ resist two import first line drug isoniazid inh rifampicin rif enhanc inform avail direct optim treatment patient becton dickinson co januari
incom statement
non-
per share item
balanc sheet
product perform develop
valuat consensu perform
becton dickinson co januari
compar
roa roi roe
actual vs price-to-earnings ratio ttm price-to-earnings high last yr price-to-earnings last yr beta price sale ttm price book mrq price ttm price free ttm errorerrorerror own dividend yield dividend yield year average dividend year growth rate pay-out ratio ttm sale mrq vs qtr yr sale ttm vs ttm yr sale yr growth rate sale yr growth rate ep mrq vs qtr yr ep ttm vs ttm yr ep yr growth rate ep yr growth rate capit spend yr growth rate lt debt equiti mrq total debt equiti mrq interest coverag ttm gross margin ttm gross margin yr average ebitd margin ttm ebitd yr average oper margin ttm oper margin yr average pre-tax margin ttm pre-tax margin yr average net profit margin ttm net profit margin yr average effect tax rate ttm effect tax rate yr average return asset ttm return asset yr average return invest ttm return invest yr average return equiti ttm return equiti yr average revenue/employe ttm net income/employe ttm receiv turnov ttm inventori turnov ttm asset turnov ttm manag effect effici performancevalu ratio dividend growth rate ratio profit becton dickinson co januari
consensu view analyst trend stock
forecast
compar
 average
multipl
compar
annual usdgrowth high day day day estim avgfive-year growth forecast comparisonbdxindustri avg avgprice/earn yield becton dickinson co januari
consensu view analyst trend stock
averag earn estim
current qtr
next qtr
sale growth estim current
qtr
next qtr
averag revenu estim
current qtr
estimatescurr analyst estimatethi estim estimatepast ep growthprice/earningsobsoleteobsoleteobsoleteobsoletepeg ratioobsoleteobsoleteobsoleteobsoleteconsensu ep day day day day ep last last last dayserrorerrorerrorerrordown last dayscurr growth ratescurr surprisescurr becton dickinson co januari
price target summarycrispidea trendscurr monthlast monthtwo month agothre month agostrong estcurr qtr next qtrcurrent yearnext estcurr qtr next qtrcurrent yearnext becton dickinson co januari
incom statement
non-
per share item
balanc sheet
product perform develop
valuat consensu perform
becton dickinson co januari
stock price volatil quarter dip decemb
stock price declin period averag volum share trade
 price movementvolumeclos becton dickinson co januari
stock price show huge fluctuat past surg august
stock show downward trend octob decemb
stock given return past
 price movementvolumeclos becton dickinson co januari
stock price show upward trend past surg
stock given return past
 year price movementvolumeclos becton dickinson co januari
deliv strong perform growth revenu adjust ep
increas growth due acquisit bard strong growth
across busi segment recommend buy rate stock tp
closeci target becton dickinson co januari
crispidea financi inform servic firm focus provid equiti research portfolio manag
person wealth manag brokerag servic inform servic side provid commun
consult research servic host client
crispidea track limit number compani sector strive provid qualiti insight straight
forward analysi object creat long-term wealth moder low risk crispidea leverag
larg number in-hous extern expert oper within industri strong financi oper
strateg background
detail visit www crispidea com contact
